Document Detail


Chemical function-based pharmacophore generation of selective kappa-opioid receptor agonists by catalyst and phase.
MedLine Citation:
PMID:  19205759     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two chemical function-based pharmacophore models of selective kappa-opioid receptor agonists were generated by using two different programs: Catalyst/HypoGen and Phase. The best output hypothesis (Hypo1) of HypoGen consisted of five features: one hydrogen-bond acceptor (HA), three hydrophobic points (HY), and one positive ionizable function (PI). The highest scoring model (Hypo2) produced by Phase comprised four features: one acceptor (A), one positive ionizable function (P), and two aromatic ring features (R). These two models (Hypo1 and Hypo2) were then validated by test set prediction and enrichment factors. They were shown to be able to identify highly potent kappa-agonists within a certain range, and satisfactory enrichments were achieved. The features of these two pharmacophore models were similar and consistent with experiment data. The models produced here were also generally in accord with other reported models. Therefore, our pharmacophore models were considered as valuable tools for 3D virtual screening, and could be useful for designing novel kappa-agonists.
Authors:
Jing Zhang; Guixia Liu; Yun Tang
Related Documents :
15218279 - How to write a research paper.
16995719 - Explicit diversity index (edi): a novel measure for assessing the diversity of compound...
20838969 - Bayesian methods in virtual screening and chemical biology.
8910979 - The theoretical and empirical case for in vitro developmental toxicity screens, and pot...
17030589 - Screening designs for drug development.
18043789 - A risk score to diagnose depression in general practice.
19604669 - A new bidirectional heteroassociative memory encompassing correlational, competitive an...
17445199 - Pypop update--a software pipeline for large-scale multilocus population genomics.
12915299 - The influence of hierarchy on probability judgment.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-02-11
Journal Detail:
Title:  Journal of molecular modeling     Volume:  15     ISSN:  0948-5023     ISO Abbreviation:  J Mol Model     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-07-20     Completed Date:  2009-10-13     Revised Date:  2013-03-15    
Medline Journal Info:
Nlm Unique ID:  9806569     Medline TA:  J Mol Model     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1027-41     Citation Subset:  IM    
Affiliation:
Laboratory of Molecular Modeling and Design, School of Pharmacy, East China University of Science and Technology, Box 268, 130 Meilong Road, Shanghai, 200237, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / chemistry*,  pharmacology
Analgesics, Non-Narcotic / chemistry*,  pharmacology
Catalysis
Drug Design*
Models, Molecular
Pyrrolidines / chemistry*,  pharmacology
Quantitative Structure-Activity Relationship
Receptors, Opioid, kappa / agonists*,  antagonists & inhibitors,  chemistry*
Software
Chemical
Reg. No./Substance:
0/Analgesics, Non-Narcotic; 0/Pyrrolidines; 0/Receptors, Opioid, kappa; 115199-84-3/ICI 199441; 67198-13-4/3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Theoretical kinetic study of the formation reactions of methanol and methyl hypohalites in the gas p...
Next Document:  Analysis of oligomeric proteins during unfolding by pH and temperature.